By Brenda Goodman, CNN(CNN) — The US Food and Drug Administration plans to make changes soon to the lengthy black box warning on many hormone replacement products for women with menopause symptoms, Commissioner Dr. Martin Makary said. After the study and the label change, prescriptions for hormone replacement therapy drugs for women dropped by more than 70%, and doctors became reluctant to prescribe them. Makary also said hormone replacement therapy may also have important benefits like reducing bone loss, heart disease risk and memory loss,“Women live longer and feel better on hormone replacement therapy when started before age 60,” Makary told Gupta. The potential change follows a July meeting of experts, convened by the FDA, to discuss the benefits and risks of hormone replacement therapy for women. “And please stop harming women.”Some women’s health experts say the FDA overstepped when it applied the boxed warning to all forms of estrogen replacement.